Source: Eur Respir J, 56 (4) 2001720; 10.1183/13993003.01720-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Benedicte De Muynck, Anke Van Herck, Annelore Sacreas, Tobias Heigl, Janne Kaes, Arno Vanstapel, Stijn E. Verleden, Arne P. Neyrinck, Laurens J. Ceulemans, Dirk E. Van Raemdonck, Katrien Lagrou, Bart M. Vanaudenaerde, Geert M. Verleden, Robin Vos. Successful Pseudomonas aeruginosa eradication improves outcomes after lung transplantation: a retrospective cohort analysis. Eur Respir J, 56 (4) 2001720; 10.1183/13993003.01720-2020

Member's Comments

No comment yet.

Related content which might interest you: The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis Source: Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017 Year: 2018 Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Pseudomonas infection risk in bronchiectasis: A retrospective cohort analysis of longitudinal microbiology in 174 patients Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Pseudomonas aeruginosa in patients with cystic fibrosis - a comparison of early eradication and conventional therapy Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 Pseudomonas eradication management in COPD: results from a single centre Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 The clinical impact of Pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral centre Source: Eur Respir J, 53 (4) 1802081; 10.1183/13993003.02081-2018 Year: 2019 Development of antibiotic-resistance in P. aeruginosa obtained from bronchiectasis patients: a multicenter prospective observational study Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 Effect of antifibrotics on short-term outcome after bilateral lung transplantation: a multicentre analysis Source: Eur Respir J, 51 (6) 1800503; 10.1183/13993003.00503-2018 Year: 2018 Survival outcomes following lung transplantation for cystic fibrosis patients infected with Burkholderia cenocepacia Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Feasibility study for a randomized controlled trial of pseudomonas aeruginosa eradication treatment in patients with bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Clinical outcomes of the patients with multidrug-resistant Acinetobacter baumannii pneumonia in critical care setting: A retrospective cohort study in Taiwan Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018 Isolation of stenotrophomonas maltophilia in lung transplant recipients: effects of treatment on prevalence and outcome Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Effect of long term treatment with azithromycin on clinical status and lung function parameters in cystic fibrosis patients colonised by pseudomonas aeruginosa Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch center of expertise Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies Year: 2018 Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis Source: Eur Respir J , 49 (4)  1600851; DOI: 10.1183/13993003.00851-2016 Year: 2017 Does a single Pseudomonas aeruginosa isolation predict COPD mortality? Source: Eur Respir J 2014; 44: 794-797 Year: 2014 Detection of antibodies against Pseudomonas aeruginosa in the sputum of cystic fibrosis patients: A pilot study Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research Year: 2012 Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020 Year: 2021 Pseudomonas aeruginosa eradication after lung transplantation: is it the tip of the iceberg? Source: Eur Respir J, 58 (1) 2004380; 10.1183/13993003.04380-2020 Year: 2021